| __timestamp | Dr. Reddy's Laboratories Limited | Travere Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 12402000000 | 47795223 |
| Thursday, January 1, 2015 | 17449000000 | 50426000 |
| Friday, January 1, 2016 | 17834000000 | 70853000 |
| Sunday, January 1, 2017 | 19551000000 | 78168000 |
| Monday, January 1, 2018 | 18265000000 | 123757000 |
| Tuesday, January 1, 2019 | 15607000000 | 140963000 |
| Wednesday, January 1, 2020 | 15410000000 | 131773000 |
| Friday, January 1, 2021 | 16541000000 | 210328000 |
| Saturday, January 1, 2022 | 17482000000 | 235780000 |
| Sunday, January 1, 2023 | 19381000000 | 244990000 |
| Monday, January 1, 2024 | 22873000000 |
Unleashing insights
In the ever-evolving pharmaceutical landscape, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Dr. Reddy's Laboratories Limited, a major player in the global pharmaceutical industry, has consistently outpaced Travere Therapeutics, Inc. in R&D investment over the past decade. From 2014 to 2023, Dr. Reddy's Laboratories increased its R&D expenses by approximately 85%, peaking in 2024 with a notable 23% rise from the previous year. In contrast, Travere Therapeutics, a smaller biotech firm, has shown a steady yet modest increase in R&D spending, with a 413% growth from 2014 to 2023. However, data for 2024 is missing, leaving room for speculation on their future trajectory. This comparison highlights the contrasting scales and strategies of these two companies, offering insights into their potential for innovation and market impact.
Comparing Innovation Spending: Bristol-Myers Squibb Company and Dr. Reddy's Laboratories Limited
R&D Spending Showdown: Genmab A/S vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Dr. Reddy's Laboratories Limited and Blueprint Medicines Corporation
Research and Development: Comparing Key Metrics for Dr. Reddy's Laboratories Limited and TG Therapeutics, Inc.
Research and Development Investment: Dr. Reddy's Laboratories Limited vs Protagonist Therapeutics, Inc.
Dr. Reddy's Laboratories Limited vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Ionis Pharmaceuticals, Inc. and Travere Therapeutics, Inc.
Research and Development Investment: Viking Therapeutics, Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Xenon Pharmaceuticals Inc. vs Travere Therapeutics, Inc.
Research and Development Expenses Breakdown: Arrowhead Pharmaceuticals, Inc. vs Travere Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Travere Therapeutics, Inc. and Viridian Therapeutics, Inc.
R&D Insights: How Travere Therapeutics, Inc. and MiMedx Group, Inc. Allocate Funds